Douglas Cubbin

Douglas Cubbin

Health Technology
Commercial Services
Transportation

Profile

Douglas Cubbin is Co-Chief Executive Officer at Telix Pharmaceuticals (France) SAS since 2018.
Mr. Cubbin is Non-Executive Chairman at Cyclopharm Ltd. starting in 2026.
Mr. Cubbin is Director at Telix Innovations SA (Belgium) since 2018.
Mr. Cubbin is a Member of the Australian Institute of Company Directors.
Former roles include Executive Chairman at ANSTO Nuclear Medicine Pty Ltd., Non-Executive Director at OncoSil Medical Ltd. from 2025 to 2025, General Manager-Business Development at Australian Nuclear Science & Technology Organisation, Group Chief Financial Officer at DHL Global Forwarding (Australia) Pty Ltd., and Group Chief Financial Officer at Telix Pharmaceuticals Ltd. from 2017 to 2022.

Douglas Cubbin active positions

CompaniesPositionStart
CYCLOPHARM LIMITED Chairman 07/05/2026
Corporate Officer/Principal -
Director/Board Member 20/12/2018
Chief Executive Officer 27/09/2018

Former positions of Douglas Cubbin

CompaniesPositionEnd
ONCOSIL MEDICAL LIMITED Chairman 30/09/2025
TELIX PHARMACEUTICALS LIMITED Director of Finance/CFO 30/07/2022
Australian Nuclear Science & Technology Organisation
Corporate Officer/Principal -
ANSTO Nuclear Medicine Pty Ltd.
Chairman -
Director of Finance/CFO -
See the detail of Douglas Cubbin's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

95

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Commercial Services

Australian Nuclear Science & Technology Organisation

Transportation

Health Technology

Health Technology

Distribution Services

ANSTO Nuclear Medicine Pty Ltd.

  1. Stock Market
  2. Insiders
  3. Douglas Cubbin